Vaccinations

Our Health Advisory Council, a group of expert healthcare professionals working in coeliac disease from across the UK, recommends that a diagnosis of coeliac disease does not increase the risk of side effects or complications after vaccination.

Covid-19 priority groups for vaccination

Two vaccinations have now been approved for use in the UK and priority groups have been provisionally established for the roll out of both vaccines. Currently, adults aged 16-65 with reduced spleen function are listed under priority group 6.

Around a third of adults with coeliac disease may have reduced spleen function and so adults with coeliac disease may fall into this group. Coeliac disease is listed within the vaccination guidance as an example of a condition which may lead to splenic dysfunction. You can read more about spleen function in coeliac disease on our website.

Click here to view the full list of the Government's COVID-19 vaccination first phase priority groups. 

Allergic reactions following covid-19 vaccination

Anaphylaxis is a severe allergic reaction and can be seen in response to foods, medicines and vaccines. Coeliac disease is an autoimmune disease and is not a food allergy.

Whether or not diagnosed with coeliac disease, people who have had an allergic reaction to a previous dose of covid-19 vaccine, or a component of the covid-19 vaccine should not be given the vaccination. Anyone due to receive their vaccine should continue with their appointment and discuss any questions, serious allergies or any other medical conditions with the healthcare professional before having the vaccine.